Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Cancer Discovery
|
June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Nature Medicine
|
November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
AKT Inhibition in Solid Tumors With AKT1 Mutations
David M Hyman, Lillian M Smyth, Mark T A Donoghue, et al.
Cancer Discovery
|
March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Nature Genetics
|
November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesis
Preethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2018
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Tara E Soumerai, Mark T A Donoghue, Chaitanya Bandlamudi, et al.
JCO Precision Oncology
|
August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
Wassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
The New England Journal of Medicine
|
February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Cancer Discovery
|
November 11, 2017
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
Yelena Y Janjigian, Francisco Sanchez-Vega, Philip Jonsson, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Cancer Discovery
|
June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
Alexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Nature Medicine
|
November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
AKT Inhibition in Solid Tumors With AKT1 Mutations
David M Hyman, Lillian M Smyth, Mark T A Donoghue, et al.
Cancer Discovery
|
March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.
Nature Genetics
|
November 6, 2021
The context-specific role of germline pathogenicity in tumorigenesis
Preethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2018
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Tara E Soumerai, Mark T A Donoghue, Chaitanya Bandlamudi, et al.
JCO Precision Oncology
|
August 22, 2017
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
Wassim Abida, Joshua Armenia, Anuradha Gopalan, et al.
The New England Journal of Medicine
|
February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Cancer Discovery
|
November 11, 2017
Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
Yelena Y Janjigian, Francisco Sanchez-Vega, Philip Jonsson, et al.
Page
of 18